🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Advanced NRAS-Mutant Melanoma

A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors NCT07584226Phase 19 sites📍 Los Angeles📍 San Francisco📍 Aurora Relay Therapeutics, Inc. · Tests: RLY-8161 RWS of Tunlametinib in NRAS-Mutant Advanced Melanoma NCT07445022Phase 41 site📍 Shanghai Fudan University · Tests: tunlametinib Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma NCT06008106Phase 31 site📍 Beijing Shanghai Kechow Pharma, Inc. · Tests: tunlametinib, paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma NCT07449754Phase 210 sites📍 Seongnam-si📍 Hwasun📍 Busan Hanmi Pharmaceutical Company Limited · Tests: Belvarafenib, Cobimetinib
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy